A new study of hydroxychloroquine shows the drug helped COVID-19 patients survive but scientists still debate its use. According to a study at Detroit's Henry Ford Health System, 13% fewer hospitalized patients died if they were given the drug.
Speaking with reporters, White House Trade Advisor Peter Navarro spoke about the effectiveness of early intervention, going into detail about the cellular structure of the "China virus." He said that "science says there's a high probability this has a prophylactic ability" and blamed the media for "hydroxy hysteria."
When asked if the President should have taken it, Navarro said "it's a good decision."